Physician profile
Ravichandra Reddy
NPI 1326029588
$279.23
in general payments reported to CMS, 2019-2025
11 companies · $153 in 2025
The $153 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.01 · 2021: $46.83 · 2023: $24.43 · 2024: $41.84 · 2025: $153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $219.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $219.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $92.50 | 2025 | Vyepti |
| Exact Sciences Corporation | $28.94 | 2025 | Cologuard Collection Kit |
| Averitas Pharma INC. | $26.89 | 2024 | Qutenza |
| Lilly USA, LLC | $24.43 | 2023 | Mounjaro |
| Ferring Pharmaceuticals INC. | $17.68 | 2025 | Euflexxa |
| Pfizer INC. | $17.44 | 2021 | |
| Abbott Laboratories | $15.85 | 2021 | |
| Inspire Medical Systems, INC. | $14.95 | 2024 | Inspire |
| Phadia US INC. | $14.00 | 2025 | Immunocap |
| Horizon Therapeutics Plc | $13.54 | 2021 | |
| Novo Nordisk INC | $13.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ravichandra Reddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.